• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4632670)   Today's Articles (1697)   Subscriber (49924)
For: Kastelic D, He M. Ribosome display and screening for protein therapeutics. Methods Mol Biol 2012;899:61-72. [PMID: 22735946 DOI: 10.1007/978-1-61779-921-1_4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Number Cited by Other Article(s)
1
Ribosome Display Technology: Applications in Disease Diagnosis and Control. Antibodies (Basel) 2020;9:antib9030028. [PMID: 32605027 PMCID: PMC7551589 DOI: 10.3390/antib9030028] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 06/06/2020] [Accepted: 06/08/2020] [Indexed: 12/28/2022]  Open
2
Xiangbao Y, Linquan W, Mingwen H, Fan Z, Kai W, Xin Y, Kaiyang W, Huaqun F. Humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles, an antibody conjugate with potent and selective anti-hepatocellular carcinoma activity. Biomed Pharmacother 2014;68:597-602. [DOI: 10.1016/j.biopha.2014.04.006] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2014] [Accepted: 04/16/2014] [Indexed: 12/14/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA